Yu Pang

496 total citations
24 papers, 359 citations indexed

About

Yu Pang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yu Pang has authored 24 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Yu Pang's work include Ubiquitin and proteasome pathways (3 papers), Cancer-related gene regulation (2 papers) and Myasthenia Gravis and Thymoma (2 papers). Yu Pang is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Cancer-related gene regulation (2 papers) and Myasthenia Gravis and Thymoma (2 papers). Yu Pang collaborates with scholars based in China, Canada and United States. Yu Pang's co-authors include Meng Li, Jie Lv, Yulong Lin, S. Hu, Shuangling Wang, Bo Han, Tingting Feng, Jinxiang Han, Jindan Yu and Lin Wang and has published in prestigious journals such as Analytical Chemistry, Cancer Research and Chemical Engineering Journal.

In The Last Decade

Yu Pang

19 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Pang China 8 121 81 73 59 54 24 359
Minghua Jiang China 12 237 2.0× 95 1.2× 38 0.5× 39 0.7× 32 0.6× 52 526
Mehdi Karimi‐Shahri Iran 13 152 1.3× 141 1.7× 49 0.7× 15 0.3× 58 1.1× 27 502
Zhou Wei China 11 112 0.9× 45 0.6× 25 0.3× 44 0.7× 31 0.6× 21 308
Weixi Jiang China 15 137 1.1× 261 3.2× 104 1.4× 111 1.9× 63 1.2× 22 574
Nan Yu China 10 144 1.2× 34 0.4× 46 0.6× 41 0.7× 36 0.7× 33 357
Junwei Cui China 14 276 2.3× 31 0.4× 51 0.7× 68 1.2× 64 1.2× 37 515
Qin Xiao China 11 324 2.7× 91 1.1× 57 0.8× 21 0.4× 46 0.9× 21 466
Wenhai Deng China 13 129 1.1× 80 1.0× 36 0.5× 30 0.5× 213 3.9× 29 476
Ping Leng China 8 166 1.4× 68 0.8× 40 0.5× 32 0.5× 27 0.5× 13 407

Countries citing papers authored by Yu Pang

Since Specialization
Citations

This map shows the geographic impact of Yu Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Pang more than expected).

Fields of papers citing papers by Yu Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Pang. The network helps show where Yu Pang may publish in the future.

Co-authorship network of co-authors of Yu Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Pang. A scholar is included among the top collaborators of Yu Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Pang. Yu Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoyu, Chunming Xu, Hui Tian, et al.. (2025). FeS embedded bioreactor collaborate with artesunate for cascade-catalytic tumor ferroptosis. Journal of Colloid and Interface Science. 692. 137479–137479. 5 indexed citations
2.
3.
Ma, Da, Yu Pang, Shan Xiao, et al.. (2024). Unveiling metabolite network dynamics during Pu-erh tea storage via non-targeted metabolomics. LWT. 209. 116789–116789. 4 indexed citations
4.
Chai, Qiyao, Zehui Lei, Yiru Wang, et al.. (2024). LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis. EMBO Molecular Medicine. 16(8). 1755–1790. 6 indexed citations
5.
Zhang, Qian, et al.. (2024). Hyocholic acid: A novel therapeutic strategy for metabolic syndrome. 2(4). 100093–100093.
6.
Liu, Shujie, Kun Wang, Yu Pang, et al.. (2024). miR‐451a suppresses the proliferation and migration of high‐grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway. The Journal of Gene Medicine. 26(1). e3649–e3649.
7.
Pang, Yu, et al.. (2023). Thymus and lung mucosa-associated lymphoid tissue lymphoma with adenocarcinoma of the lung: a case report and literature review. World Journal of Surgical Oncology. 21(1). 20–20. 1 indexed citations
8.
9.
Pang, Yu, et al.. (2022). Spirometra mansoni sparganosis identified by metagenomic next-generation sequencing: a case report. International Journal of Infectious Diseases. 128. 128–131. 2 indexed citations
10.
Pang, Yu, et al.. (2022). Intraductal Papillary Mucinous Neoplasm Arising from Heterotopic Pancreas in Stomach: A Case Report and Review of Literature. International Journal of Surgical Pathology. 31(5). 708–713.
11.
12.
Li, Xiaomei, Min Lin, Juan Xu, et al.. (2021). New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern. Breast Cancer. 28(6). 1383–1388. 7 indexed citations
13.
Zhou, Bin, et al.. (2021). Small cell neuroendocrine carcinoma expressing alpha fetoprotein in the endometrium. Open Life Sciences. 16(1). 1219–1224. 2 indexed citations
14.
Lu, Ruirui, Junqi Chen, Bihao Liu, et al.. (2020). Protective role of Astragaloside IV in chronic glomerulonephritis by activating autophagy through PI3K/AKT/AS160 pathway. Phytotherapy Research. 34(12). 3236–3248. 21 indexed citations
15.
Qi, Mei, Jing Hu, Meng Jiao, et al.. (2019). CUL4B promotes prostate cancer progression by forming positive feedback loop with SOX4. Oncogenesis. 8(3). 23–23. 24 indexed citations
16.
Wang, Xueli, Mei Qi, Jing Zhang, et al.. (2019). Differential response to neoadjuvant hormonal therapy in prostate cancer: Predictive morphological parameters and molecular markers. The Prostate. 79(7). 709–719. 20 indexed citations
17.
Tan, Yaoju, Biyi Su, Wei Shu, et al.. (2018). Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013–2016. BMC Pulmonary Medicine. 18(1). 168–168. 47 indexed citations
18.
Wang, Lin, Guanhua Song, Xiang Zhang, et al.. (2017). PADI2-Mediated Citrullination Promotes Prostate Cancer Progression. Cancer Research. 77(21). 5755–5768. 77 indexed citations
19.
Zhang, Peng, Chunlin Yang, Yu Pang, et al.. (2017). ONX-0914, a selective inhibitor of immunoproteasome, ameliorates experimental autoimmune myasthenia gravis by modulating humoral response. Journal of Neuroimmunology. 311. 71–78. 30 indexed citations
20.
Song, Haibo, et al.. (2015). Safety and risk factor analysis on Polygoni Multiflori Radix base on ancient traditional Chinese medicine literatures. China Journal of Chinese Materia Medica. 40(5). 985–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minghua Jiang Breakdown of academic impact, for papers by Mehdi Karimi‐Shahri Breakdown of academic impact, for papers by Zhou Wei Breakdown of academic impact, for papers by Weixi Jiang Breakdown of academic impact, for papers by Nan Yu Breakdown of academic impact, for papers by Junwei Cui Breakdown of academic impact, for papers by Qin Xiao Breakdown of academic impact, for papers by Wenhai Deng Breakdown of academic impact, for papers by Ping Leng
Rankless by CCL
2026